WallStreetZenWallStreetZen

NASDAQ: CLGN
Collplant Biotechnologies Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CLGN

Based on 2 analysts offering 12 month price targets for Collplant Biotechnologies Ltd.
Min Forecast
$11.00+49.25%
Avg Forecast
$16.88+128.97%
Max Forecast
$22.75+208.68%

Should I buy or sell CLGN stock?

Based on 2 analysts offering ratings for Collplant Biotechnologies Ltd.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLGN stock forecasts and price targets.

CLGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 44%
57
BuyMaintains$11.00+44.17%2023-03-30
Alliance Global Partners
Bottom 1%
1
Strong BuyInitiates Coverage On$22.75+198.17%2023-02-17

1 of 1

Forecast return on equity

Is CLGN forecast to generate an efficient return?
Company
N/A
Industry
0.07%
Market
71.27%

Forecast return on assets

Is CLGN forecast to generate an efficient return on assets?
Company
N/A
Industry
0.1%

CLGN revenue growth forecast

How is CLGN forecast to perform vs Biotechnology companies and vs the US market?
Company
513.93%
Industry
39.99%
Market
8.44%
CLGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLGN$7.63$16.88+121.17%Strong Buy
DARE$1.01$7.00+593.07%Buy
DTIL$0.77$10.50+1,268.97%Buy
RVLP$0.88$3.50+297.73%Strong Buy
LYRA$2.70$20.00+640.74%Strong Buy
View Top Biotech Stocks

Collplant Biotechnologies Stock Forecast FAQ

Is Collplant Biotechnologies Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CLGN) stock is to Strong Buy CLGN stock.

Out of 2 analysts, 1 (50%) are recommending CLGN as a Strong Buy, 1 (50%) are recommending CLGN as a Buy, 0 (0%) are recommending CLGN as a Hold, 0 (0%) are recommending CLGN as a Sell, and 0 (0%) are recommending CLGN as a Strong Sell.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.

What is CLGN's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CLGN) forecast ROE is N/A, which is considered weak.

What is CLGN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CLGN price target, the average CLGN price target is $16.88, with the highest CLGN stock price forecast at $22.75 and the lowest CLGN stock price forecast at $11.00.

On average, Wall Street analysts predict that Collplant Biotechnologies's share price could reach $16.88 by Mar 30, 2024. The average Collplant Biotechnologies stock price prediction forecasts a potential upside of 121.17% from the current CLGN share price of $7.63.

What is CLGN's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CLGN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.